Key facts
- This page summarizes John M. Hamm's Form 4 filing for CUMBERLAND PHARMACEUTICALS INC (CPIX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 20 Mar 2026, 17:20.
John M. Hamm - 18 Mar 2026 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)
- Reporting relationship
- VP Chief Financial Officer
- Issuer ticker
- CPIX
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Mar 2026, 17:20:31 UTC
- Prior SEC filing
- 18 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- John Hamm
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John M. Hamm filed Form 4 for CUMBERLAND PHARMACEUTICALS INC (CPIX) on 20 Mar 2026.
Change
- Previous filing in this sequence was filed on 18 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001870439
Primary reporting owner
Hamm John M.
- Relationship
- VP Chief Financial Officer
- Address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE
- Signature
- John Hamm
- Signature date
- 20 Mar 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CPIX
transaction
Derivative
Options (right to buy)
Award
- Transaction value
- Shares
- +3,000
- Change %
- +20%
- Price
- $2.80*
- Shares after
- 18,250
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,000
- Exercise price
- $2.80
* marks a reported price that did not pass the local price check.